Funding Organization: National Institutes of Health (NIH)
Total Funding Amount: $700,000 for the fiscal year 2026
Duration: Up to 2 years
Primary Objective: To encourage revision applications from currently funded NCI U01 research projects to incorporate new technical approaches or devices.
Key Stakeholders: NCI, research communities, cancer patients.
Funding Source: Federal government.
Significance: Supports the development of innovative technologies for cancer research.
Grant Frequency: One-time funding opportunity.
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits (with and without 501(c)(3) status)
For-Profit Organizations (including Small Businesses)
Local, State, County, City Governments
Indian/Native American Tribal Governments
Federal Agencies
Foreign Organizations
Active registration in System for Award Management (SAM)
Unique Entity Identifier (UEI)
Registration in eRA Commons
Grants.gov registration
Cancer risk identification and reduction strategies
Improvement of screening and early detection strategies
Development of accurate diagnostic techniques
Mechanisms for cancer prevention and interventions
Independent validation of emerging technologies
Enhanced rigor of new findings in cancer research
Knowledge of NCI-supported technologies
Experience in cancer research methodologies
Maximum budget: $150,000 in direct costs per year
No cost sharing required
Open Date: March 4, 2025
Application Due Date: October 3, 2025
Expiration Date: October 4, 2025
Compliance with NIH Grants Policy Statement
Adherence to ethical standards and regulations
Applications must be submitted electronically via Grants.gov
Follow specific instructions in the Application Guide